|
Re: American Association for Cancer Research 2019
|
2
|
Zenith Epigenetics
|
Mar 29, 2019 09:05PM
|
|
Re: A vs V
|
2
|
Resverlogix Corp.
|
Mar 29, 2019 07:59PM
|
|
Re: No mention of efficacy again...
|
5
|
Resverlogix Corp.
|
Mar 29, 2019 03:41PM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
3
|
Resverlogix Corp.
|
Mar 29, 2019 02:37PM
|
|
Re: No mention of efficacy again...
|
8
|
Resverlogix Corp.
|
Mar 29, 2019 02:13PM
|
|
Re: List of things that point to postive data.
|
2
|
Resverlogix Corp.
|
Mar 28, 2019 10:09PM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
1
|
Resverlogix Corp.
|
Mar 28, 2019 08:14PM
|
|
Re: No mention of efficacy again...
|
1
|
Resverlogix Corp.
|
Mar 28, 2019 05:41PM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
4
|
Resverlogix Corp.
|
Mar 28, 2019 02:58PM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
1
|
Resverlogix Corp.
|
Mar 28, 2019 01:30PM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
3
|
Resverlogix Corp.
|
Mar 28, 2019 01:22PM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
1
|
Resverlogix Corp.
|
Mar 28, 2019 12:26PM
|
|
DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
3
|
Resverlogix Corp.
|
Mar 28, 2019 10:42AM
|
|
Re: This is sort off topic but not really.
|
1
|
Zenith Epigenetics
|
Mar 28, 2019 07:03AM
|
|
Re: No mention of efficacy again...
|
3
|
Resverlogix Corp.
|
Mar 27, 2019 04:04PM
|
|
Re: No mention of efficacy again...
|
6
|
Resverlogix Corp.
|
Mar 27, 2019 01:52PM
|
|
Resverlogix Announces Ninth Positive DSMB Recommendation for Phase 3 Study of Apabetalone
|
1
|
Resverlogix Corp.
|
Mar 27, 2019 12:20PM
|
|
AD/PD Posters
|
1
|
Resverlogix Corp.
|
Mar 27, 2019 12:02PM
|
|
Fabry Disease More Common Than Previously Thought, Experts Say
|
1
|
Resverlogix Corp.
|
Mar 27, 2019 11:13AM
|
|
Re: Blog post up on Seeking Alpha....lots of changes.
|
3
|
Resverlogix Corp.
|
Mar 27, 2019 11:07AM
|
